Role of β-lactamase inhibitors on cefiderocol activity against carbapenem-resistant Acinetobacter species
Author:
Funder
Ministry of Health
National Institutes of Health
Publisher
Elsevier BV
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine
Reference6 articles.
1. New treatment options for multiresistant gram negatives;Paterson;Curr Opinion Infect Dis,2020
2. Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial;Bassetti;Lancet Infect Dis,2021
3. Targeting multidrug-resistant Acinetobacter spp.: Sulbactam and the diazabicyclooctenone beta-lactamase inhibitor ETX2514 as a novel therapeutic agent;Barnes;mBio,2019
4. A new twist: The combination of sulbactam/avibactam enhances sulbactam activity against carbapenem-resistant Acinetobacter baumannii (CRAB) isolates;Pasteran;Antibiotics (Basel),2021
5. Contribution of PER-type and NDM-type ss-lactamases to cefiderocol resistance in Acinetobacter baumannii;Poirel;Antimicrob Agents Chemother,2021
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Challenges Facing Two Outbreaks of Carbapenem-Resistant Acinetobacter baumannii: From Cefiderocol Susceptibility Testing to the Emergence of Cefiderocol-Resistant Mutants;Antibiotics;2024-08-21
2. Hetero-antagonism of avibactam and sulbactam with cefiderocol in carbapenem-resistant Acinetobacter spp.;Microbiology Spectrum;2024-08-20
3. Induced Heteroresistance in Carbapenem-Resistant Acinetobacter baumannii (CRAB) via Exposure to Human Pleural Fluid (HPF) and Its Impact on Cefiderocol Susceptibility;International Journal of Molecular Sciences;2023-07-21
4. Comparison of Disk Diffusion, E-Test, and Broth Microdilution Methods for Testing In Vitro Activity of Cefiderocol in Acinetobacter baumannii;Antibiotics;2023-07-20
5. Inhibition of Enzymatic Acetylation-Mediated Resistance to Plazomicin by Silver Ions;Pharmaceuticals;2023-02-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3